LSM2 and cancer: We investigated mutations of LSM genes in BRCA patients from TCGA Pan-Cancer Atlas (n = 1082 patients) in the cBioPortal platform, and found surprisingly high rates of alterations in LSM1 (25%), LSM2 (11%) LSM4 (8%), and LSM14B (23%).